Collaborate Disseminate
Manufacturing the groundbreaking and extremely popular diabetes and weight-loss drug semaglutide – Ozempic, Wegovy – is a complex, slow process. Amid ongoing global shortages, researchers have developed a cheaper, faster method that produces ten times … Continue reading Global Ozempic shortage fix: Cheaper, faster method produces 10x more
Next-gen anti-obesity drugs like injectable liraglutide, sold as Saxenda, deliver impressive results in the first 12 months. New research looks into what happens to those results once treatment stops.Continue ReadingCategory: Health & Wellbeing, Li… Continue reading What happens when you go off weight-loss drugs?
In yet another surprise attribute of the new class of obesity drugs, scientists have found that GLP-1 receptor agonists can also subdue brain inflammation, giving them a potential ‘superpower’ in the fight against Alzheimer’s and Parkinson’s diseases.
Tags: University of Toronto, Ozempic, GLP1, Alzheimer’s Disease, Parkinson’s Disease, Inflammatory, Brain, Dementia
Continue reading GLP-1 weight-loss drugs may pivot to treat Alzheimer’s and Parkinson’s
New research has found that patients taking the weight-loss and diabetes drug semaglutide had significantly reduced symptoms of alcohol use disorder. Although the study was small, larger studies are underway with the potential to lead to the use of dru… Continue reading Ozempic drug may add addiction treatment to its growing list of uses
New research has found that signals linked to how food tastes are sent from our mouths to our brains almost immediately to slow our eating pace, with the well-known stretch signals from the gut coming later. The findings provide insights into how diffe… Continue reading Food taste found to rein in eating within seconds, before gut stretch
Managing diabetes usually involves regular shots of insulin or other drugs, but soon patients might only need to inject themselves a few times a year. Stanford has developed a hydrogel-based delivery system that slowly releases drugs over months to con… Continue reading Slow-release diabetes drugs could cut shots from daily to 3 times a year
The US has officially got a homegrown hero in the burgeoning global industry of effective weight-loss treatments, with the FDA approval of Eli Lilly’s Zepbound. The company has announced the once-a-week injectable drug’s cost, dosages, insurance subsid… Continue reading US and UK give the green light to powerful weight loss drug